Psychedelic evolution: Mindset Pharma looks to change mental health treatment
The BioWorld Insider Podcast

Psychedelic evolution: Mindset Pharma looks to change mental health treatment

Sep 21, 2022
25:48
S1 · E22
-(0)

About this episode

James Lanthier, the CEO of Mindset Pharma Inc., talks about developing next-generation psychedelic medicines to treat neurological and psychiatric disorders. Hosted on Acast. See acast.com/privacy for more information.

Comments

Rate this episode

Episode Details

Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy